26 reports

Serious mental illnesses include schizophrenia, bipolar disorder and recurrent major depressive disorder.

  • Cancer
  • Medical Biotechnology
  • Specialty Hospital
  • Therapy
  • United States

Pyschiatric Hospitals specialize in the treatment of serious mental disorders such as clinical depression, schizophrenia, and bipolar disorder.

  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Kindred Healthcare, Inc.
  • Universal Health Services, Inc.
  • PUBLIC PSYCHIATRIC HOSPITALS

Particular issues treated include manic episodes, bipolar disorder, depressive episodes and recurrent depression.

  • Health Services
  • Hospital
  • Specialty Hospital
  • Australia
  • Demand

In addition, individuals with a bipolar disorder (i. e. manic depression) who maintain a regimen of lithium are much less likely to relapse than those not taking the medication.

  • Addiction Disorder
  • Mental Health
  • Specialty Hospital
  • United States
  • Demand

(Australia) ##.

  • Specialty Hospital
  • United States
  • Demand
  • Market Competition
  • Market Shares

Gaucher disease is one of about ## lysosomal storage disorders.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Carlsson Research AB Pfizer Inc Phase IV Phase III Phase II Phase I/ II Phase I TOTAL ## ## ## ## ## ## ## ## ## ## ## ## Noxopharm Ltd Merz Pharma GmbH & Co KgaA ## ## ## ## ## ## ## ## ## ## ## ## Kyowa Hakko Europe GmbH ## ## ## ## ##

  • Clinical Trial
  • Specialty Hospital
  • World
  • Product Initiative
  • Pfizer Inc.

Its test is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive compulsive disorder, attention deficit hyperactivity disorder, bipolar disorder, post-traumatic stress disorder, autism, schizophrenia, chro

  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States
  • Cocrystal Pharma, Inc.
  • 5. All the trials included are unique trials.

GDCT ID is the unique ID of GlobalData' s Pharma Intelligence Center clinical trial database Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Biomarker(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor

  • Clinical Trial
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • World

Its test is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive compulsive disorder, attention deficit hyperactivity disorder, bipolar disorder, post-traumatic stress disorder, autism, schizophrenia, chro

  • Genomics
  • Medical Device
  • Specialty Hospital
  • United States
  • Deals & Alliance

This makes this project vital in recognizing and correcting control issues for patients with problems like depression and bipolar disorder.

  • Diagnostic Imaging
  • Hospital
  • Specialty Hospital
  • United States
  • Company

In contrast, the strongest enrichments of heritability for bipolar disorder were in excitatory neurons.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • Company

Some depressed patients have been diagnosed with other mood disorders such as schizophrenia or bipolar disorder - conditions that have also lacked biological markers and objective treatment strategies.

  • Ambulatory Care
  • Cancer
  • Health Services
  • Specialty Hospital
  • United States

FAP is an inherited disorder that occurs in about ## in ##, ## people.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States

Other studies have shown the level of the gene encoding Chrdl## is altered in schizophrenia and bipolar disorder, suggesting that Chrdl## may have important roles in both health and disease.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • OCT 18, 2017: PATIENTS WITH SERIOUS MENTAL HEALTH CONDITIONS RECEIVE PREVENTIVE CARE AT RATES SIMILAR TO THOSE WITHOUT THESE CONDITIONS

The proposed clinical trial will evaluate MN-## (ibudilast) as a potential treatment for individuals diagnosed with MA use disorder with or without post-traumatic stress disorder (PTSD).

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Specialty Hospital
  • United States

Therapy Area Central Nervous System Hematological Disorders Infectious Disease Metabolic Disorders Oncology Pharmaceuticals and Healthcare No. of Deals ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA Note: Deals include all announ

  • Health Services
  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • United States

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • Australia

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States

Its products are indicated for the treatment of diseases such as Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease, among others.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States

Its products are indicated for the treatment of diseases such as Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease, among others.

  • Health Services
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States

It develops cellular therapies for hematological disorders and immunological diseases.

  • Cancer
  • Specialty Hospital
  • United States
  • Company
  • Juno Therapeutics Inc.

As part of the research and development activities, MSD has entered into a research collaboration with CTx focusing on blood disorders, which MSD will fund.

  • Specialty Hospital
  • Therapy
  • United Kingdom
  • Company
  • Cancer Research Technology Limited

It invests in the areas of cancer, inflammation, infectious disease, metabolic disorders, cardiovascular disease, and nervous system disorders.

  • Cancer
  • Specialty Hospital
  • United States
  • Company
  • MabVax Therapeutics Holdings Inc.

As part of the research and development activities, MSD has entered into a research collaboration with CTx focusing on blood disorders, which MSD will fund.

  • Specialty Hospital
  • Therapy
  • United Kingdom
  • Company
  • Cancer Research Technology Limited

AltheaDx offers products and services to therapeutic areas of hypertension, musculoskeletal pain, hyperhomocysteinemia, bipolar disorder, neuropathic pain, anxiety, arrhythmia, depression, arthritis and migraine.

  • Clinical Trial
  • Diagnostics
  • Prostate Cancer
  • Specialty Hospital
  • bioMerieux S.A.